Clinically relevant resistance in cancer chemotherapy

Gespeichert in:
Bibliographische Detailangaben
Format: Buch
Sprache:English
Veröffentlicht: Boston [u.a.] Kluwer 2002
Schriftenreihe:Cancer treatment and research [112]
Schlagworte:
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

MARC

LEADER 00000nam a2200000zcb4500
001 BV014639878
003 DE-604
005 20050228
007 t
008 020806s2002 xxuad|| |||| 00||| eng d
020 |a 1402072007  |9 1-4020-7200-7 
035 |a (OCoLC)50280120 
035 |a (DE-599)BVBBV014639878 
040 |a DE-604  |b ger  |e aacr 
041 0 |a eng 
044 |a xxu  |c US 
049 |a DE-355  |a DE-12 
050 0 |a RC271.C5 
082 0 |a 616.99/4061  |2 21 
084 |a XH 3220  |0 (DE-625)152888:12926  |2 rvk 
245 1 0 |a Clinically relevant resistance in cancer chemotherapy  |c ed. by Borje Andersson ... 
264 1 |a Boston [u.a.]  |b Kluwer  |c 2002 
300 |a XX, 380 S.  |b Ill., graph. Darst. 
336 |b txt  |2 rdacontent 
337 |b n  |2 rdamedia 
338 |b nc  |2 rdacarrier 
490 1 |a Cancer treatment and research  |v [112] 
500 |a Includes bibliographical references and index 
650 7 |a Cancer - Chimiothérapie  |2 ram 
650 7 |a Cellules cancéreuses - Résistance aux médicaments  |2 ram 
650 2 |a Résistance aux médicaments antinéoplasiques 
650 4 |a Drug Resistance, Neoplasm  |x physiology 
650 4 |a Drug resistance in cancer cells 
650 4 |a Neoplasms  |x drug therapy 
650 0 7 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |2 gnd  |9 rswk-swf 
650 0 7 |a Chemotherapie  |0 (DE-588)4127083-6  |2 gnd  |9 rswk-swf 
650 0 7 |a Therapieresistenz  |0 (DE-588)4133317-2  |2 gnd  |9 rswk-swf 
650 0 7 |a Cytostatikum  |0 (DE-588)4068347-3  |2 gnd  |9 rswk-swf 
650 0 7 |a Arzneimittelresistenz  |0 (DE-588)4143180-7  |2 gnd  |9 rswk-swf 
655 7 |0 (DE-588)4143413-4  |a Aufsatzsammlung  |2 gnd-content 
689 0 0 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |D s 
689 0 1 |a Chemotherapie  |0 (DE-588)4127083-6  |D s 
689 0 2 |a Arzneimittelresistenz  |0 (DE-588)4143180-7  |D s 
689 0 |5 DE-604 
689 1 0 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |D s 
689 1 1 |a Cytostatikum  |0 (DE-588)4068347-3  |D s 
689 1 2 |a Arzneimittelresistenz  |0 (DE-588)4143180-7  |D s 
689 1 |5 DE-604 
689 2 0 |a Krebs  |g Medizin  |0 (DE-588)4073781-0  |D s 
689 2 1 |a Chemotherapie  |0 (DE-588)4127083-6  |D s 
689 2 2 |a Therapieresistenz  |0 (DE-588)4133317-2  |D s 
689 2 |5 DE-604 
700 1 |a Andersson, Börje  |e Sonstige  |4 oth 
830 0 |a Cancer treatment and research  |v [112]  |w (DE-604)BV000001082  |9 112 
999 |a oai:aleph.bib-bvb.de:BVB01-009942565 

Datensatz im Suchindex

_version_ 1804129405141778432
any_adam_object
building Verbundindex
bvnumber BV014639878
callnumber-first R - Medicine
callnumber-label RC271
callnumber-raw RC271.C5
callnumber-search RC271.C5
callnumber-sort RC 3271 C5
callnumber-subject RC - Internal Medicine
classification_rvk XH 3220
ctrlnum (OCoLC)50280120
(DE-599)BVBBV014639878
dewey-full 616.99/4061
dewey-hundreds 600 - Technology (Applied sciences)
dewey-ones 616 - Diseases
dewey-raw 616.99/4061
dewey-search 616.99/4061
dewey-sort 3616.99 44061
dewey-tens 610 - Medicine and health
discipline Medizin
format Book
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02351nam a2200625zcb4500</leader><controlfield tag="001">BV014639878</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20050228 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">020806s2002 xxuad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1402072007</subfield><subfield code="9">1-4020-7200-7</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)50280120</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV014639878</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">xxu</subfield><subfield code="c">US</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.C5</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99/4061</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3220</subfield><subfield code="0">(DE-625)152888:12926</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Clinically relevant resistance in cancer chemotherapy</subfield><subfield code="c">ed. by Borje Andersson ...</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Boston [u.a.]</subfield><subfield code="b">Kluwer</subfield><subfield code="c">2002</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XX, 380 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Cancer treatment and research</subfield><subfield code="v">[112]</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer - Chimiothérapie</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cellules cancéreuses - Résistance aux médicaments</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Résistance aux médicaments antinéoplasiques</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug Resistance, Neoplasm</subfield><subfield code="x">physiology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Drug resistance in cancer cells</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapieresistenz</subfield><subfield code="0">(DE-588)4133317-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Cytostatikum</subfield><subfield code="0">(DE-588)4068347-3</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelresistenz</subfield><subfield code="0">(DE-588)4143180-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Chemotherapie</subfield><subfield code="0">(DE-588)4127083-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="2"><subfield code="a">Therapieresistenz</subfield><subfield code="0">(DE-588)4133317-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Andersson, Börje</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Cancer treatment and research</subfield><subfield code="v">[112]</subfield><subfield code="w">(DE-604)BV000001082</subfield><subfield code="9">112</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009942565</subfield></datafield></record></collection>
genre (DE-588)4143413-4 Aufsatzsammlung gnd-content
genre_facet Aufsatzsammlung
id DE-604.BV014639878
illustrated Illustrated
indexdate 2024-07-09T19:04:37Z
institution BVB
isbn 1402072007
language English
oai_aleph_id oai:aleph.bib-bvb.de:BVB01-009942565
oclc_num 50280120
open_access_boolean
owner DE-355
DE-BY-UBR
DE-12
owner_facet DE-355
DE-BY-UBR
DE-12
physical XX, 380 S. Ill., graph. Darst.
publishDate 2002
publishDateSearch 2002
publishDateSort 2002
publisher Kluwer
record_format marc
series Cancer treatment and research
series2 Cancer treatment and research
spelling Clinically relevant resistance in cancer chemotherapy ed. by Borje Andersson ...
Boston [u.a.] Kluwer 2002
XX, 380 S. Ill., graph. Darst.
txt rdacontent
n rdamedia
nc rdacarrier
Cancer treatment and research [112]
Includes bibliographical references and index
Cancer - Chimiothérapie ram
Cellules cancéreuses - Résistance aux médicaments ram
Résistance aux médicaments antinéoplasiques
Drug Resistance, Neoplasm physiology
Drug resistance in cancer cells
Neoplasms drug therapy
Krebs Medizin (DE-588)4073781-0 gnd rswk-swf
Chemotherapie (DE-588)4127083-6 gnd rswk-swf
Therapieresistenz (DE-588)4133317-2 gnd rswk-swf
Cytostatikum (DE-588)4068347-3 gnd rswk-swf
Arzneimittelresistenz (DE-588)4143180-7 gnd rswk-swf
(DE-588)4143413-4 Aufsatzsammlung gnd-content
Krebs Medizin (DE-588)4073781-0 s
Chemotherapie (DE-588)4127083-6 s
Arzneimittelresistenz (DE-588)4143180-7 s
DE-604
Cytostatikum (DE-588)4068347-3 s
Therapieresistenz (DE-588)4133317-2 s
Andersson, Börje Sonstige oth
Cancer treatment and research [112] (DE-604)BV000001082 112
spellingShingle Clinically relevant resistance in cancer chemotherapy
Cancer treatment and research
Cancer - Chimiothérapie ram
Cellules cancéreuses - Résistance aux médicaments ram
Résistance aux médicaments antinéoplasiques
Drug Resistance, Neoplasm physiology
Drug resistance in cancer cells
Neoplasms drug therapy
Krebs Medizin (DE-588)4073781-0 gnd
Chemotherapie (DE-588)4127083-6 gnd
Therapieresistenz (DE-588)4133317-2 gnd
Cytostatikum (DE-588)4068347-3 gnd
Arzneimittelresistenz (DE-588)4143180-7 gnd
subject_GND (DE-588)4073781-0
(DE-588)4127083-6
(DE-588)4133317-2
(DE-588)4068347-3
(DE-588)4143180-7
(DE-588)4143413-4
title Clinically relevant resistance in cancer chemotherapy
title_auth Clinically relevant resistance in cancer chemotherapy
title_exact_search Clinically relevant resistance in cancer chemotherapy
title_full Clinically relevant resistance in cancer chemotherapy ed. by Borje Andersson ...
title_fullStr Clinically relevant resistance in cancer chemotherapy ed. by Borje Andersson ...
title_full_unstemmed Clinically relevant resistance in cancer chemotherapy ed. by Borje Andersson ...
title_short Clinically relevant resistance in cancer chemotherapy
title_sort clinically relevant resistance in cancer chemotherapy
topic Cancer - Chimiothérapie ram
Cellules cancéreuses - Résistance aux médicaments ram
Résistance aux médicaments antinéoplasiques
Drug Resistance, Neoplasm physiology
Drug resistance in cancer cells
Neoplasms drug therapy
Krebs Medizin (DE-588)4073781-0 gnd
Chemotherapie (DE-588)4127083-6 gnd
Therapieresistenz (DE-588)4133317-2 gnd
Cytostatikum (DE-588)4068347-3 gnd
Arzneimittelresistenz (DE-588)4143180-7 gnd
topic_facet Cancer - Chimiothérapie
Cellules cancéreuses - Résistance aux médicaments
Résistance aux médicaments antinéoplasiques
Drug Resistance, Neoplasm physiology
Drug resistance in cancer cells
Neoplasms drug therapy
Krebs Medizin
Chemotherapie
Therapieresistenz
Cytostatikum
Arzneimittelresistenz
Aufsatzsammlung
volume_link (DE-604)BV000001082
work_keys_str_mv AT anderssonborje clinicallyrelevantresistanceincancerchemotherapy